Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.81 USD | +1.87% | +8.61% | -7.65% |
May. 02 | Transcript : Acadia Healthcare Company, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Acadia Healthcare Q1 Adjusted Earnings, Revenue Increase; Reaffirms 2024 Outlook | MT |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company is in debt and has limited leeway for investment
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.65% | 6.66B | C+ | ||
+20.68% | 85.55B | C+ | ||
-29.31% | 70.07B | B- | ||
+9.58% | 29.06B | C+ | ||
-8.63% | 17.51B | B | ||
+2.14% | 17.39B | A- | ||
+0.39% | 15.38B | A- | ||
+6.47% | 13.4B | B- | ||
+68.09% | 12.87B | C- | ||
+6.43% | 12.77B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ACHC Stock
- Ratings Acadia Healthcare Company, Inc.